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Although much is known about the addictive effects of nicotine, the molecular 
mechanisms of nicotine-induced effects remain largely unclear. Specifically, little is known 
about the effects of nicotine on gene expression, including gene expression controlled by 
miRNAs.   miRNAs may play a key role in regulating gene expression in response to nicotine 
exposure due to the fact that expression profiles of the miRNAs will be altered.  These effects on 
gene expression may be associated with long-term use and the “addictive” behavior that is often 
exhibited with use of nicotine. Our goals are to explore the toxicity of nicotine on 
Caenorhabditis elegans (C. elegans), including survival, reproduction, and gene expression and 
to develop C. elegans as a model organism to assess the toxicity of various xenobiotics. We 
hypothesize that 1) Nicotine affects survival and reproduction of C. elegans; 2) The expression 
of several important genes, including the genes coding for the nicotinic acetylcholine receptor 
and for oxidative stress response, will be affected by nicotine exposure; and 3) The expression of 
miRNA genes will be changed and related to the selected protein coding gene expression. In 
survival trials, we tested a range of doses to obtain a 24- hour dose-response data. The 24-hour 
lethal dose-20 (LD20) in C. elegans corresponds to dose of ~3.16 ppm (19.5 uM) of nicotine. A 
reproduction study revealed that even at low nicotine exposure levels, egg-laying is affected. 
  
Using qRT-PCR, we found that the expression of several egg-laying and oxidative stress related 
genes were altered by nicotine, which may be regulated by miRNAs. We were able to 
analytically determine that the expression patterns of the selected protein coding genes were 
dose-related. In the miRNA assay, we analyzed the expression of four miRNAs (Cel-mir-70, 
Cel-mir-58, Cel-mir-790, Cel-mir-253.), which were selected by in-silico prediction of miRNAs 
that potentially target our protein-coding genes of interest. We found that individual miRNA 
expression profiles varied among the different concentrations, indicating that the nicotine 
concentration induces a differential miRNA expression. At 3.16 ppm, where the protein-coding 
genes are the most active, miRNAs are also up-regulated indicating there is a complex system of 
regulation based on more than one miRNA, many miRNAs may target the same gene. Therefore, 
we believe that miRNAs may play a key role in controlling protein-coding gene expression. The 
understanding of this relationship between the toxicant (nicotine) and its effects on miRNAs and 
their targeted genes will lead to a greater understanding of mechanisms of nicotine-related 
addiction. 
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CHAPTER 1: INTRODUCTION 
 
  In 2008, nearly 71 million Americans aged 12 and older had used a tobacco 
product at least once in the month prior to being surveyed. The study also reported that 7-20% of 
8th to 12th grade students had used a smokeless tobacco product in the month prior to being 
surveyed (Kaletta…). Nicotine is the primary substance in tobacco products that leads to 
addictive behavior. It is a major component of cigarette smoke, is contained in smokeless 
tobacco products, and is a large concern for the health care industry (Table 1-1) because it plays 
a key role in the development of lung cancer and cardiovascular disease (Yildiz 2004). Nicotine 
also is a central nervous system (CNS) stimulator (Picciotto…) that is involved in excitatory 
neurotransmission that affects many bodily functions. 
Nicotine is an amine composed of pyridine and pyrrolidine rings (Figure 1-1). It has been 
shown that nicotine can cross biological membranes and the blood brain barrier easily 
(Oldendorf, Stoller et al. 1993). The absorbed nicotine is almost completely metabolized in the 
liver to form a wide selection of metabolites (Yildiz 2004). It has been shown to affect a large 
variety of functions including gene expression, regulation of hormone secretion, and enzyme 
activities (Yildiz 2004). 
The primary target of nicotine is the nicotinic acetylcholine receptors (nAChRs) (Schafer 
2002; Darsow, Booker et al. 2005).  nAChRs are protein receptors that are located in the cellular 
membrane of the neuromuscular junction (Melstrom and Williams 2007). The nAChRs are 
included in a family of ligand-gated ion channels and contribute to many of the important 
processes in the brain, including cognitive and memory functions (Yu, Nordberg et al. 2003).  
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After being stimulated by nicotine, nAChRs regulate the function of pathways involved 
in many actions in the body. Some of these include: stress response, anxiety, and depression in 
the normal brain. Smoking and consequent uptake of nicotine can result in the changing of 
anxiety levels and mood (Yu, Nordberg et al. 2003). At the cellular level, stimulation of these 
nicotinic receptors leads to an increased synthesis and extracellular release of several hormones 
such as norepinephrine and epinephrine (Yildiz 2004). 
Oxidative stress is one of the effects of nicotine exposure. Oxidative stress is defined as 
‘‘a disturbance in the pro-oxidant-antioxidant balance in favor of the former, leading to potential 
damage’’ (Mary B. Newman and Thomas Tighea 2002). This imbalance can be caused by an 
increase in reactive oxygen species (ROS). Not much is known about the production of reactive 
oxygen species (ROS) upon nicotine exposure. The increase in ROS increases oxidative damage 
to the cellular membranes (Mary B. Newman and Thomas Tighea 2002). Mechanisms for coping 
with the oxidative stress include up regulation of radical detoxifying enzymes that are capable of 
converting free radicals to less toxic substances, such as glutathione - peroxidase, super-oxide 
dismutase (SOD), and catalase (Mary B. Newman and Thomas Tighea 2002). 
Although much is known about the effects of nicotine on the nAChRs, little is known 
about its effects on specific nAChRs subunits, genes implicated in behavioral abnormalities, and 
potential microRNAs (miRNA) regulation of specific genes (Takahashi, Yamashita et al. 1999). 
miRNAs are short endogenous RNAs known to be major gene regulators. One study indicated 
that the miRNA regulated pathway is one of the cellular mechanisms involved in nicotine 
dependence (Li 2009). This study suggested that the DRD1 gene, which is shown to be involved 
in nicotine dependence, is differentially expressed when up regulated by miR-504 expression. 
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These effects on gene expression may be the cause of the “addictive” behavior that leads to long 
term use of nicotine. 
Need for an animal model 
Approximately 60%–80% of C. elegans’ genes are conserved with humans (Vella 2005). 
This similarity suggests that C. elegans would be an appropriate model for understanding 
toxicological pathways at the gene or protein level in humans. It is important to note that while 
C. elegans and humans are similar in term of conserved genes, they are different in terms of 
pathological and phenotypical expression. There are several other characteristics that are shared 
between the phyla, including molecular and cellular pathways (Vella 2005). The entire genome 
sequence of C. elegans is known. Among the 18,452 known C. elegans protein sequences, at 
least 83% (15,344 sequences) have human homologous genes (Narahashi, Fenster et al. 2000).  
In 1965 Sydney Brenner proposed C. elegans as a model organism for scientific research 
and it has been used for various types of studies, including: apoptosis, cell signaling, cell cycle, 
cell polarity, gene regulation and metabolism (Narahashi, Fenster et al. 2000). C. elegans are one 
of the most amenable, well-defined organisms that have a nervous system. This animal model is 
very easy to culture and maintain. The average adult worm is 1mm, they are free-living (non-
parasitic), and can live on E.-coli lawned nematode growth medium (NGM). The small size of C. 
elegans allows in vivo assays to be performed. They have a short lifecycle/lifespan (3.5days/3 
weeks), which allows for assays to be performed rapidly with larger numbers of organisms 
(Culetto and Sattelle 2000). 
C. elegans are transparent, which allows the cell lineage and other parts of the body be 
easily studied under light microscopes. In addition, the known sequence of the entire genome 
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facilitates genetic manipulations for the creation of transgenic strains for particular studies 
(Culetto and Sattelle 2000). 
Gonad development          
In our studies, we plan to use larval stage 3 (L3) animals. For this reason it is important to 
understand how to identify C. elegans at various stages in development. One method that is used 
to determine the relative age of these worms is to look at the gonad development. This is called 
gonadogenesis, which starts approximately 7 hr after hatching. As seen in (Figure 1-2), the size 
and characteristics of the gonad vary at the different stages (Sulston and Brenner 1974; Hillier, 
Coulson et al. 2005). Figure 1-2 provides a cartoon representation of the development and 
characterization of the gonad cells. Primordial gonad cells are formed in L1. The four celled 
gonadal primordium (Z1-Z4) is shown in its midventral position in the newly hatched worm 
(Kimble and Hirsh 1979).  
In hermaphrodite worms, the Z1 and Z4 cells give rise to the somatic structures of the 
gonad, and Z2 and Z3 give rise to the germ line cells (Kimble and Hirsh 1979). During the 
second half of L1, 12 cells are produced by the somatic gonad precursors Z1 and Z4 in the 
hermaphrodite worm (Kimble and Hirsh 1979). In hermaphrodites, the developing gonad 
elongates both anteriorly and posteriorly during L1, L2, and L3. The growing tips, as seen in 
(Figure 1-3), reflex around the time of the L3-L4 molt (Sulston and Brenner 1974; Hillier, 
Coulson et al. 2005). Germ cells increase in number in L2. The gonad has extended along the 
ventral body in L3. During L3-early L4, somatic gonad precursors yield a total of 143 cells, 
forming the anterior and posterior gonadal sheaths, the spermathecae and the uterus. The distal 
gonad arms continue their migration along the dorsal body wall muscles and by the L4/adult 
molt they complete their migration close to midline (Sulston and Brenner 1974; Hillier, Coulson 
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et al. 2005). At this time the vulva is open to the outside and uterus is full of fertilized eggs in the 
adult. At this stage, the hermaphrodite begins to lay eggs and completes its life cycle. 
C. elegans microRNAs (miRNA) 
The role of miRNAs in gene expression is to control a diverse range of processes, 
including cell fate specification, apoptosis, developmental timing, diseases, and metabolism 
(Sulston and Brenner 1974; Lee 2001). The very first miRNA identified in C. elegans was lin-4, 
discovered and reported by Victor Ambros and colleagues in 1993 (Vella 2005). Current 
literature indicates that 175 miRNAs have been identified in C. elegans so far (MIR-Base). Many 
of the C. elegans miRNAs are highly evolutionarily conserved across many species, i.e. from 
flies to humans (Lai, Chou et al. 2000; Narahashi, Fenster et al. 2000; Nass and Hamza 2007). 
The transcription of the miRNA genes is performed by RNA polymerase II, resulting in 
primary miRNA transcripts (pri-miRNA) (Roush and Slack 2009).  Similarly to the protein-
coding targets of RNA Pol II, pri-miRNAs are processed into pre-miRNAs in the nucleus by the 
microprocessor complex (Denli, Tops et al. 2004) . The premiRNAs are then exported to the 
cytoplasm by Exportin 5 where they are further processed by Dicer into mature miRNAs (Yi, 
Qin et al. 2003; Dempsey, Mackenzie et al. 2005).  
The mechanism for the biogenesis of the C. elegans miRNAs is a well-known process 
and occurs in a manner very similar to mammals.  After the transcription of a miRNA gene, 
nuclear cleavage of the pri-miRNA by the Drosha RNase III endonucleases occurs. This enzyme 
cuts both strands of the pri-miRNA near the stem loop and generates ~60–70 nt stem-loop 
shaped miRNA precursor (pre-miRNA) (Sulston and Brenner 1974). This pre-miRNA is 
transported to the cytoplasm by the export receptor Exportin-5. The nuclear cut by Drosha 
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defines one end of the mature miRNA and cytoplasmic cut by Dicer, also RNase III 
endonuclease, defines the opposite one. Dicer recognizes the pre-miRNA and cuts both of its 
strands at about two helical turns away from the base of the stem loop. Then one of these ~ 22 nt 
miRNA duplex arms is chosen and mature miRNA is associated with RNA-induced silencing 
complex (RISC) (Vella 2005). Once incorporated into a cytoplasmic RISC, the miRNA will 
specify cleavage if the miRNA has sufficient complementarity to the mRNA, or it will repress 
productive translation if the miRNA does not have sufficient complementarity. These miRNAs 
down-regulate gene expression by interacting with partially complementary sequences in the 3' 
UTRs of their target genes (Sulston and Brenner 1974).  
I hypothesize that nicotine exposure in C. elegans mediates miRNA gene expression dose-
dependently, leading to cytotoxicity, decreased survival and reproduction, and alterations to 
protein coding gene expression. 
 
To test this hypothesis, this project will identify dose dependent effects on survival and 
reproduction, and investigate differential expression patterns of both protein coding genes and 
miRNA genes after  exposure to nicotine. My specific objectives are:  
1. Evaluate the cytotoxicity (represented by mortality) and reproductive effects 
(represented by egg-laying pattern) of  nicotine exposure on C. elegans (Chapter 3) 
 
2. Analyze selected protein coding gene expression in C. elegans after exposure to 
nicotine (Chapter 4) 
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RT-PCR and TaqMan qRT-PCR assays were used to determine protein-coding 
gene expressions in C. elegans after exposure to nicotine.     
 
3. Analyze selected miRNA expression in C. elegans after exposure to nicotine 
(Chapter 5) 
RT-PCR and TaqMan qRT-PCR assays were used to determine miRNA gene 
expression profiles in C. elegans after exposure to nicotine.     
 
 
 8 
 
References 
 
Bartel, D. P. (2004). "MicroRNAs: genomics, biogenesis, mechanism, and function." Cell 
116(2): 281-97. 
Culetto, E. and D. B. Sattelle (2000). "A role for Caenorhabditis elegans in understanding the 
function and interactions of human disease genes." Hum Mol Genet 9(6): 869-77. 
Darsow, T., T. K. Booker, et al. (2005). "Exocytic trafficking is required for nicotine-induced 
up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors." J Biol Chem 280(18): 
18311-20. 
Feng, Z., W. Li, et al. (2006). "A C. elegans model of nicotine-dependent behavior: regulation by 
TRP-family channels." Cell 127(3): 621-33. 
Health, N. S. o. D. U. a. (2008). "Nicotine Dependence: 2006." 
Hillier, L. W., A. Coulson, et al. (2005). "Genomics in C. elegans: so many genes, such a little 
worm." Genome Res 15(12): 1651-60. 
Huang, W. and M. D. Li (2009). "Nicotine modulates expression of miR-140*, which targets the 
3'-untranslated region of dynamin 1 gene (Dnm1)." Int J Neuropsychopharmacol 12(4): 
537-46. 
Kaletta, T. and M. O. Hengartner (2006). "Finding function in novel targets: C. elegans as a 
model organism." Nat Rev Drug Discov 5(5): 387-98. 
Kimble, J. and D. Hirsh (1979). "The postembryonic cell lineages of the hermaphrodite and male 
gonads in Caenorhabditis elegans." Dev Biol 70(2): 396-417. 
Lagos-Quintana, M., R. Rauhut, et al. (2002). "Identification of tissue-specific microRNAs from 
mouse." Curr Biol 12(9): 735-9. 
Lai, C. H., C. Y. Chou, et al. (2000). "Identification of novel human genes evolutionarily 
conserved in Caenorhabditis elegans by comparative proteomics." Genome Res 10(5): 
703-13. 
Li, W. H. a. M. D. (2009). "Differential Allelic Expression of Dopamine D1 Receptor 
Gene (DRD1) Is Modulated by microRNA miR-504." BIOL PSYCHIATRY 65: 702–705. 
 9 
 
Mary B. Newman, G. W. A., R. Douglas Shytlea, Paula C. Bickforda, and P. R. S. Thomas 
Tighea (2002). "Nicotine’s oxidative and antioxidant properties in CNS." Life Sciences 
71 71: 2807–2820. 
Melstrom, P. C. and P. L. Williams (2007). "Reversible AChE inhibitors in C. elegans vs. rats, 
mice." Biochem Biophys Res Commun 357(1): 200-5. 
Narahashi, T., C. P. Fenster, et al. (2000). "Symposium overview: mechanism of action of 
nicotine on neuronal acetylcholine receptors, from molecule to behavior." Toxicol Sci 
57(2): 193-202. 
Oldendorf, W. H., B. E. Stoller, et al. (1993). "Blood-brain barrier penetration abolished by N-
methyl quaternization of nicotine." Proc Natl Acad Sci U S A 90(1): 307-11. 
Picciotto, M. R., D. H. Brunzell, et al. (2002). "Effect of nicotine and nicotinic receptors on 
anxiety and depression." Neuroreport 13(9): 1097-106. 
Schafer, W. R. (2002). "Genetic analysis of nicotinic signaling in worms and flies." J Neurobiol 
53(4): 535-41. 
Sulston, J. E. and S. Brenner (1974). "The DNA of Caenorhabditis elegans." Genetics 77(1): 95-
104. 
Takahashi, T., H. Yamashita, et al. (1999). "Effects of nerve growth factor and nicotine on the 
expression of nicotinic acetylcholine receptor subunits in PC12 cells." Neurosci Res 
35(3): 175-81. 
Vella, M. C. a. S., F.J. (2005). "C. elegans microRNAs ". 
Yildiz, D. (2004). "Nicotine, its metabolism and an overview of its biological effects." Toxicon 
43: 619–632. 
Yu, W. F., A. Nordberg, et al. (2003). "Correlation of oxidative stress and the loss of the 
nicotinic receptor alpha 4 subunit in the temporal cortex of patients with Alzheimer's 
disease." Neurosci Lett 338(1): 13-6. 
 
 
 
 
 
 
 10 
 
Table 1-1. The effects of nicotine in whole organisms and in cells  
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Table 1-2. Past Month Nicotine Dependence among Past Month Cigarette Users Aged 12 or 
Older, by Age Group, Race/Ethnicity, and Annual Family Income  
 
 
 
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 
(January 24, 2008). The NSDUH Report: Nicotine Dependence: 2006. Rockville, MD. 
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(Figure 1-1) Molecular structure of (+/-)-Nicotine (C10H14N2) 
 
http://www.edinformatics.com/interactive_molecules/3D/nicotine_molecule.htm 
 
[1]Hoffmann, Dietrich, and Ilse Hoffmann. "Chemistry and Toxicology." Smoking and Tobacco 
Control Monograph No. 9: 55-104. Web. 14 Mar. 2011. 
<http://dccps.nci.nih.gov/tcrb/monographs/9/m9_3.PDF>. 
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(Figure 1-2) C. elegans life cycle at 220C 
 
 
CAENORHABDITIS Elegans AS A GENETIC ORGANISM." Worm Atlas. Web. 5 Oct. 2010. 
<http://www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro.htm>. 
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(Figure 1-3). Cartoon representation of post-embryonic hermaphrodite gonad development. 
Comparative size of gonads at different stages is not to scale.  
WormBook: The Online Review of C. elegans Biology [Internet]. 
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(Figure 1-4) Predicted stem loops of the founding miRNAs, lin-4 and let-7 RNAs (Lee et al., 
1993;Reinhart et al., 2000). The precise sequences of the mature miRNAs were defined by 
cloning (Lau et al., 2001). Shown are the C. elegans stem loops, but close homologs of both have 
been found in flies and mammals (Pasquinelli et al., 2000; Lagos-Quintana et al., 2001, 2002). 
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(Figure 1-5). Biogenisis of miRNA  
http://en.wikipedia.org/wiki/File:MiRNA-biogenesis.jpg 
 
 
 
 
  
CHAPTER 2: Assay of 24 hour mortality in Caenorhabditis elegans following nicotine 
administration 
 
Abstract:  
 
Although much is known about the addictive effects of nicotine, the molecular 
mechanisms of the effects induced by exposure to nicotine remain ambiguous. The goal of this 
study was to explore the toxic effects of nicotine on Caenorhabditis elegans (C. elegans) and 
underlying molecular mechanisms that control many of the processes in the worm. This chapter 
reports the lethal effect of nicotine on C. elegans. A quantal dose response relationship, which is 
an all-or-none response, was performed to attain the 24 hour lethality of different nicotine doses. 
By modifying a previously established protocol (Williams 1999), we were able to synchronize 
and dose the L3 worms in order to obtain the lethal dose 20% (LD20) after exposure to various 
concentrations of nicotine for 24 hours (Stiernagle 2006). The results of this study show that 
there is a dose-response relationship of C. elegans mortality to nicotine exposure. 
 
Introduction: 
 
The quantal lethal dose assay is a standard toxicological assay that allows for the 
determination the lethal doses of toxicants in a given population. Caenorhabditis elegans is well 
suited for toxicological studies due to its established biology, short generation time, and large 
number of prodigy (Bischof, Huffman et al. 2006). Quantitative parameters of C. elegans that 
can be assayed include growth, size, progeny production, behavior, and mortality (Roh, Park et 
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al. 2009). The cellular complexity and the conservation of disease pathways between C. elegans 
and higher organisms, together with the simplicity and cost-effectiveness of cultivation, make for 
an effective in vivo model that lends itself to whole-organism assays. The next two chapters 
describe the reproduction and mortality assays we used to analyze the toxic effects of exposure 
to nicotine on C. elegans.  
 
Materials and methods: 
 
Synchronization  
Wild type C. elegans strain Bristol N2 were grown in Petri dishes on 6-cm nematode 
growth medium (NGM) and fed with Escherichia coli strain OP50 according to a standard 
protocol (Brenner 1974). Worms at larval stage 3 (L3) from an age-synchronized culture were 
used in all experiments. To produce age-synchronized cultures, eggs from mature adults were 
isolated using a synchronization solution, followed by rinsing with M9 buffer (Roh, Park et al. 
2009). After rinsing worms were placed on an NGM plate with no food for an arresting period to 
ensure all worm were closely synchronized. L3 worms were used because of their similarity in 
life cycle in relation to the teenage years in humans. 
The worm were then transferred to OP50 seeded NGM agar plates, resulting in 
synchronized adult worm populations. L3 worms were washed out using M9, rinsed, and then 
centrifuged at 2000 rpm for 2 min at room temperature. A 2uL sample was taken and placed on a 
slide and counted under an inverse microscope to estimate the number of worms (Stiernagle 
 19 
 
2006). Once we had the estimate of the number of worms per mL we calculated how many uL 
were needed to obtain ~50 worms per sample. The was performed in triplicate for each sample 
taken.  This amount was then transferred to 1.5 mL microcenterfuge tubes with the dosing 
solution made of k-medium and the appropriate amount of nicotine. Each tube was labeled 
according to the dosage that was placed in that tube. 
 
 
Preparation of Nicotine Treatment 
A stock of 1,000 ppm nicotine was made from ACROSS organics L-nicotine, 98% pure 
(CAS 54-11-5) product. This was made by combining 10uL of L-nicotine with 9,990uL of K-
media. Five doses were chosen to test: control (0ppm), 1ppm, 3.16ppm, 10ppm, 31.6ppm (which 
corresponds to 6.17µM, 19.5µM, 61.7µM, and 194.5µM, respectively) 
 
C. elegans Treatment 
Briefly, each test consisted of four concentrations and a control, in which ~50 L3 stage 
worms were transferred to 1.5mL microcenterfuge tubes with the dosing solution. Desired 
concentrations of doses were made in 1 mL quantities from the 1,000 ppm stock and the aliquots 
were placed in the corresponding 1.5 mL microcenterfuge tubes.  These tubes were placed into a 
rotator in a 200C incubator at 42 rpm.  The worms were exposed to the nicotine doses for 24 ± 
0.5 hours. 
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Mortality Assay  
After 24 hours the worms were collected, rinsed, and transferred to 12 well tissue culture 
plates filled with 1 mL NGM agar. The worms were allowed to acclimate to the new 
environment for one hour and then counted for survivability/mortality. The numbers of live and 
dead worms were determined via visual inspection using a dissecting microscope.  If lethality 
could not be determined, the worms were probed with a platinum wire (Dhawan 1999).  The 
worms that were not moving and did not respond to gentle probing were counted as dead. 
Statistical differences between the control and exposed worms were determined using standard 
statistical software (SPSS). Analysis of variance (ANOVA) was used for comparing means of 
different treatment groups. If there was a significant difference among treatment groups at p < 
0.05 level, least significant difference (LSD) multiple comparisons were conducted to compare 
the mean of each group. The mean and standard deviation were also calculated. 
Results: 
Effects of Nicotine on C. elegans survivability 
Figure 2-1 shows the results of the lethality vs. dose w. The results show that there is a 
dose response relationship between mortality and nicotine dosing. Increases in the doses of 
nicotine increased mortality by 4.37% (1ppm), 7.47 (3.16ppm), 14.53% (10ppm), and finally 
20.61% (31.6ppm). 
The linear model was performed on both the regular data and the logarithmic transformed 
dose data.  The logarithmic dose transformation was preformed due to the fact out chosen dose 
correspond to a 0.5 log dose scale. The goodness of fit and significance of the regression model 
are shown in Table 2-1. All regression models for both the regular and the logarithmic 
 21 
 
transformed dose data were concluded to be significant by p values of < 0.001. The correlation 
coefficient R2 value for the regression models are as follows: regular dose data linear .831, log 
dose data linear 0.818.  
  
Discussion: 
Exposure to nicotine at a concentration greater than 3.16 ppm for 24 hour induced 
significantly higher mortality rate as compared to control (P < 0.05). The lethal effects followed 
a dose-response pattern as we defined four distinct statistical groups as nicotine concentration 
increased. The dose-response pattern is well described by a simple linear regression model, and 
LD 20 was determined at approximately 26 ppm (160.4 uM).  
Studies that have shown that nicotine can activate nicotine-sensitive receptor conductance 
at concentrations as low as 1 mM (1000uM) (Richmond and Jorgensen 1999). The drug that is 
up taken through the C. elegans cuticle can vary as compared to that of its environment (Matta, 
Balfour et al. 2007).  Therefore, it is critical to generate a dose–response curve on mortality 
especially at low concentrations where the genetic response may be evident.  
The low dose effects of nicotine are important to investigate due to the fact that most 
smokers fall in to this range of nicotine exposure. The average full strength cigarette contains 
1mg (equal to 55.5uM or 9ppm) of nicotine. The LD50 of nicotine is 40–60 mg (equal to 2220 
uM or 360ppm) can be a lethal dosage for adult humans (Landoni 1991). Those statistics 
combined with the fact that the average number of cigarettes consumed by a smoker is 13-14 per 
day indicates an alarming amount of nicotine being administered to smokers’ everyday if you 
multiply the amount of nicotine in one cigarette by the number smoked in one day the amount of 
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nicotine jumps to 721.5uM or 117 ppm. That is approximately one-third of the LD50 amount. 
These amounts of nicotine needed to observe these cytotoxic effects are higher in humans than 
the concentrations worked with in this study on C. elegans but understanding the cytotoxic 
effects at lower concentrations can give us a better idea of a safer range of exposure. 
 
   
Conclusion: 
 In this study we performed the initial range-finding tests between 0 ppm and 31.6 ppm of 
nicotine. We concluded that there is a dose response relationship of C. elegans mortality and 
nicotine exposure. We determined the 24 hr LD20 of the toxicant nicotine as 26 ppm (160.4 
uM).  
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Figure 2-1. Lethality vs. Dose. Effects of different doses of nicotine on C. elegans mortality rate. 
L3 C. elegans were dosed for 24 hours then counted to obtain mortality. Around 50 
worms were placed in each well in triplicate for one biological replicate. We preformed 
four biological replicates totaling ~600 worms for each dose. Error bars located on the 
bars indicate a 95% confidence interval. This means that 95% of the data is contained 
within the error bars, this works well to remove outliers that can affect the data. 
Statistical analysis was performed by the one-way Analysis of Variance (ANOVA) test 
using PASW Statistics 17 software. Different letters on bars indicated distinct statistical 
groups. The mortality of > 3.16 ppm groups is significantly higher than the control. 
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Figure 2-2. Lethality vs. Dose. Both Linear and Quadratic regression models of the lethality of 
nicotine in C. elegans. Correlation and significance can be found in Table 2-1 
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Figure 2-3. Lethality vs. Log Dose. Both Linear and Quadratic regression models of the lethality 
of nicotine in C. elegans. Equations, correlation, and significance can be found in Table 
2-1 
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Table 2-1 Linear and Quadratic Regressions for the regular and logarithmic data sets 
 
 Regression method Equation R2 Sig. 
Regular dose data Linear y=.57x + 5.7 .831 .000 
Logarithmic dose data Linear y=13.95x + 1.32 .818 .000 
 
 
 
 
 
  
CHAPTER 3: C. elegans egg laying and viability assay 
 
Abstract:  
 
Although much is known about the addictive effects of nicotine, the molecular 
mechanisms of nicotine-induced effects remain largely unclear. Our goals are to explore the 
toxicity effects of nicotine on Caenorhabditis elegans (C. elegans). In this chapter of the study 
we look at the effects of the nicotine dosing on egg-laying and viability. One of the primary 
targets of nicotine is nicotinic acetylcholine receptors (nAChRs) which mediate fast 
neurotransmission in nerves and muscles, some of which control the sex-specific muscles 
involved in C. elegans egg lying(Kim, Poole et al. 2001; Mongan, Jones et al. 2002). After 
exposing the C. elegans to various concentrations of nicotine, we performed an egg laying assay, 
counting the number of eggs laid by each worm. Each worm was placed in a separate well of a 
24-well tissue culture plate. Eggs were counted every 12 hours for the duration of the egg laying 
event. 
 
Introduction: 
One of the most important behaviors for the analysis of nicotine toxicity in C. elegans is 
the mechanism of egg-laying. C. elegans hermaphrodites are self-fertile; they produce both 
sperm, which is stored in the spematheca, and oocytes (Schafer 2005). Egg-laying in C. elegans 
occurs within the first day of the L4/adult molt, the fertilized eggs are stored in the uterus, and a 
young adult hermaphrodite will generally have a store of 10–15 eggs in its uterus at any given 
time (Schafer 2005). Once egg-laying occurs, eggs are expelled from the uterus through the 
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contraction of 16 vulval and uterine muscles (White 1986; Kim, Poole et al. 2001). When in the 
presence of favorable conditions (food, temperature, and space), wild-type animals lay eggs in a 
specific temporal pattern: egg-laying tends to be clustered in short bursts, or active phases, which 
are separated by longer inactive phases during which eggs are not laid (Wei Geng 2005). Many 
neurotransmitters and neuronal signal transduction pathways have been shown to have specific 
effects on egg laying behavior; therefore it has become an important behavioral assay for the 
analysis of many toxicological effects on such mechanisms in C. elegans (Wei Geng 2005). 
Egg-laying occurs through a simple movement involving specialized smooth muscle 
cells, when the muscles contract, they open the vulva and compress the uterus so that eggs can be 
laid in the environment. The egg-laying muscles are controlled by two classes of motor neurons 
(White 1986; Chen, Harris et al. 2005). The egg laying event occurs as the worms become young 
adults ~65 hr after hatching at 200C (Altun 2009). The event lasts for ~63 hr (2.5 days) and eggs 
are laid in clustered episodes with gaps between the events (Wei Geng 2005). Egg-laying 
behavior in C. elegans is regulated by multiple neurotransmitters, including acetylcholine and 
serotonin (Dempsey, Mackenzie et al. 2005). 
Nicotine is a known target substrate for the nicotinic acetylcholine receptors (nAChRs) in 
the mammalian CNS and subunits of these receptors have also been identified in C. elegans. 
Nicotinic acetylcholine receptors (nAChRs) mediate fast excitatory neurotransmission in neurons 
and muscles. There are a total of 13 nAChR α subunits that control many functions such as 
signal transmission, locomotion, and muscle contraction (Gottschalk, Almedom et al. 2005).  
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Materials and methods: 
 
Synchronization 
 
C. elegans were grown in Petri dishes on 6 cm nematode growth medium (NGM) and fed 
OP50 strain Escherichia coli according to a standard protocol (Brenner 1974). Laval stage 
3hermaphrodite animals from an age-synchronized culture were used in all the experiments. To 
produce age-synchronized cultures, at 2–3 days, eggs from mature adults were isolated using a 
synchronization solution, followed by rinsing with M9 buffer (Hitchcock 1998). After rinsing 
worms were placed on an NGM plate with no food for an arresting period to ensure all worm 
were closely synchronized. 
The worms were then transferred to NGM agar plates with a food source, resulting in 
synchronized adult worm populations. L3 larval stage worms were washed out using M9, rinsed, 
and then centrifuged at 2000 rpm for 2 min at room temperature a 2uL sample was taken and 
placed on a slide and counted under an inverse microscope to estimate the number of worms.  
 
 
Preparation of Nicotine Treatment 
A stock of 1,000 ppm nicotine was made from ACROSS organics L-nicotine, 98% pure 
(CAS 54-11-5) product. This was made by combining 10uL of L-nicotine with 9,990uL of 
distilled water. Five doses were chosen to test: control (0ppm), 1ppm 3.16ppm, 10ppm, 31.6ppm.  
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C. elegans Dose-Response Treatment 
Briefly, each test consisted of four concentrations and a control, in which ~50 L3 stage 
worms were transferred to 1.5 mL microcenterfuge tubes with the toxicant in each tube. Each 
was made in 1 mL quantities from the 1,000ppm stock and placed in the corresponding 1.5 
microcenterfuge tubes with the ~50 worms. These tubes were placed into a rotator at 40 rmp in 
an incubator at 200C.  The worms were exposed to the nicotine doses for 24 hours. 
 
“Picking” method of transfer  
 After 24 hours the worms were collected, rinsed, and transferred to fresh NGM plates so 
that they could be picked and placed in the wells of tissue culture plates. The picking method 
was used to pick one animal at a time. The worm picker was made by mounting a 1-inch piece of 
32 gauge platinum wire into the tip of a Pasture pipet. The end of the wire was flattened slightly 
with a hammer. To pick the worm, the tip of the wire was coated with a blob of E. coli OP50 and 
then touched gently to the top of the chosen worm, which stuck to the bacteria. The picked worm 
was transferred to the corresponding well on a 24 well NGM filled tissue culture plate, the tip 
was slowly lowered and gently touched the surface of the agar, and the worm was allowed to 
crawl off of the picker (Stiernagle 1999). 
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Method of C. elegans egg-laying and viability assay analysis  
 Once the worms had been “picked” and transferred to their respective wells, eggs that 
were laid and eventual hatched larvae were counted every 24 hrs for the duration of the egg 
laying period. The egg laying event lasts for ~63 hr (2.5 days) and eggs are laid in clustered 
episodes with gaps between the events (Wei Geng 2005).  
 
 
Results: 
 The results of this study are shown in Figure 3-1 and Figure 3-2. Dosed L3 worms were 
placed into individual wells on a 24-well cell tissue culture plate (one worm per well) that was 
seeded with E-Coli. OP-50 as food.  Eggs and larvae were counted at 24, 48 and 72 hrs after 
dosing to obtain the number of eggs laid by each worm. Statistical analysis was performed by the 
one-way Analysis of Variance (ANOVA) test using PASW Statistics 17 software. 
Figure 3-1 represents the number of eggs and larvae counted at each time point in each 
well minus the previously counted number, i.e. the values of time point 48 hour represent the 
number of newly laid eggs during the period of 24-48 hours post-dosing. . Statistical significance 
among different dosed groups was tested using SPSS within each time point. During 0 -24 hours 
post-dosing, none of the dosed groups showed a significant difference from the control (p > 
0.05). During 24-48 hours post-dosing, the 10ppm dosed group showed a significantly higher 
number of eggs plus hatched larvae as compared to control ( p = 0.015). No significant 
difference was found in other dosed groups. No other dosed groups were different from control 
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during 24-48 hours post-dosing. For the period of 48-72 hours post-dosing, there was no 
significant difference in eggs-laid of dosed groups as compared to control.  
 Figure 3-2 represents the total number of eggs and larvae counted at each time point in 
each well. Statistical significance was measured between different dosed groups within each time 
point. At time point 24hr only one of the doses showed a statistically significant difference from 
the control. Eggs laid by the 10 ppm group were significantly higher than control (p= 0.049). The 
remaining dosed groups were not significantly different as compared to control group.  
 The accumulated eggs-laid from 0-48 hours post-dosing were counted at time point 48hr. 
The result is similar to that of the 24hr count. Again the 10 ppm dosed group showed 
significantly higher eggs-laid (p= .034) as compared to control group. No differences were found 
in the remaining doses.  
 The accumulated eggs laid from 0-72 hours post-dosing were counted at time point 72hr. 
The accumulated egg-laid pattern was slightly different from the previous time points. The 
accumulated egg-laid by worms in the highest concentration group (31.6 ppm) were significantly 
higher than the control (p= 0.048), whereas other dosed groups had no significant differences.  
Figure 3-3 gives a graphical representation of total eggs laid vs. time. Three regressions 
were made on this graph: linear, quadratic and logarithmic. For each of the regressions an 
equation, R2, and a significance value were calculated; results of these calculations can be found 
in table 3-1. The three regressions gave similar results, each had a great correlation due to the R2 
values: 0.970, 0.977, and 0.973 respectively. Each also had a significance of < 0.001. Due to this 
similarity, the simplest model linear regression is sufficient to describe the egg-laying pattern 
during 0-72 hours post-dosing. 
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Discussion: 
 The egg laying patterns of C. elegans post nicotine exposure were studied over the period 
of 0-72 hours post-dosing. The pattern of egg lying was observed and charted in Figure 3-1 show 
the eggs laid pattern as divided into three time periods (0-24 hour, 24-48 hour, and 48-82 hour). 
Figure 3-2 shows the accumulated eggs laid over time (0-24 hour, 0-48 hour, and 0-72 hour). 
The overall temporal pattern of egg-laid in C. elegans is clustered and fitted into three regression 
models and is shown in Figure 3-3.  There are short periods of high-frequency egg-laying 
behavior; these short periods are called active states. During these active states approximately 1 
egg is laid a minute for 2-10 min. These egg laying events are separated by much longer periods 
of approximately 20 minutes to 1 hour long where no eggs are laid; these events are called 
inactive states (Zhang, Schafer et al.). From our data, the average number of eggs laid after 72 hr, 
approximately the completion time of the egg laying events, was 268.29 this translates to 3.77 
eggs/hr. This falls within the range of the acceptable egg laying activities of the natural egg lying 
patterns of the worms (Zhang, Schafer et al.).  
Our results indicate that nicotine exposure for 24 hours changed the egg-laying pattern at 
some doses. More eggs were laid during the 24-48 hour period at 10ppm group (Figure 3-1), 
although the total eggs laid by this group was not significantly different from control during the 
whole 0-72 hour period (Figure 3-2). The significantly higher egg-lying of the 10 ppm group 
during 0-48 hours may be attributed to the higher rate of egg-lying in the 24-48 hour section. 
More eggs were laid by the 31.6ppm dosed group as compared to control during the whole 72 
 35 
 
hour period (Figure 3-2). This finding is consistent with the literature that nicotine stimulates 
egg-laying and likely does this by activating the nicotinic acetylcholine receptors.  
From our data we generally can conclude that the effects of nicotine on egg laying are not 
measurably different than the control, until we reach the higher end of our dosing range (10 ppm 
and 31.6 ppm). Results from other studies of the number of eggs laid after exposure to 64.8 ppm 
(400 µM) yield 3 worms/2 hours resulting in only ~98 worms over the course of the egg-laying 
period (Matta, Balfour et al. 2007). The decrease in the number of eggs being laid could possibly 
be due to the fact that nicotine is stimulating the egg-laying muscles in hypercontractivity and 
therefore decreaseing the number of eggs laid  
 Regressions were performed on the data to study the relationship between time and the 
number of eggs laid. Each of the regressions, (Figure 3-3 and Table 3-1), give a strong positive 
correlation (R2 close to 1), so we can conclude that as time increases the number of eggs also 
increases. This was expected, but does not fully describe our results. Figure 3-1 shows the 
number of eggs laid minus the pervious time point’s count.  As seen in Figure 3-1, there is an 
increase in the number of eggs laid from time point 24hr to 48hr and then a slight decrease at 
time point 72 hr. This indicates that the majority of the egg laying is occurring between time 
points 24hr and 48hr. This study does not give a direct correspondence between human 
pathology and C. elegans phenotypes. Many mammalian models are often not reliably predictive 
of drug action in humans; it is merely a preclinical model perspective. Humans do not exhibit the 
phenotype of egg-laying as C. elegans do, but some of the genes that are associated with the egg-
laying behavior are known to mediate signaling pathways in humans. One example would be 
acr-16. It  has been reported to function as a nAChR in the neuromuscular junction (Touroutine, 
Fox et al. 2005). It should be noted that nicotine can affect muscle function under certain 
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conditions. For example, high concentrations of nicotine paralyze worms by acting in the muscle 
(Gottschalk, Almedom et al. 2005). While under our conditions, nAChRs seem to primarily act 
in neurons to mediate their function in nicotine responses. 
Conclusion: 
 The conclusion of this study is that  nicotine is a known effecter of some of the nicotinic 
receptors that deal with egg laying patterns, and there seems to be a slight increase in the number 
of eggs laid after exposure to higher concentrations of nicotine (10 ppm, 31.6 ppm) Also, even 
though there are statically significant values indicating that there is an effect on the egg-laying 
by time, additional time points are needed to accurately evaluate the validity of this conclusion. 
Studies with higher dosing ranges could also give a much clearer view to some of these possible 
effects. 
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Figure 3-1. Eggs Laid vs. Time. Effects of different doses of nicotine on C. elegans egg-laying 
rate. C. elegans were dosed for 24 hours then placed in individual wells to lay eggs. Eggs were 
counted at time points 24, 48, and 72 hr after being dosed. Data at the time point 24hr represent 
the number of egg laid during the period of 0-24 hr. Data at the time point 48hr represent the 
number of egg laid during the period of 24-48 hr. Data at the time point 72hr represent the 
number of egg laid during the period of 48-72 hr. This significance is indicated on Figure 3-1 as 
an uppercase “B” as compared to an uppercase “A” to show the difference from the control.  
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Figure 3-2. Total Eggs Laid vs. Time. Effects of different doses of nicotine on C. elegans total 
egg laying rate. C. elegans were dosed for 24 hours then placed  individually in 24-well 
plate to allow egg-laying. Eggs were counted at time points 24, 48, and 72 hr after being 
dosed.Data at the time point 24hr represent the number of egg laid during the period of 0-
24 hr. Data at the time point 48hr represent the number of egg laid during the period of 0-
48 hr. Data at the time point 72hr represent the number of egg laid during the period of 0-
72 hr.  
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Figure 3-3. Total Eggs Laid vs. Time. The total number of eggs that were laid at each time point 
and each dose were plotted to get a regression in order to correlate the effects of time and 
the different doses of nicotine on C. elegans total egg laying rate. C. elegans were dosed 
for 24 hours then placed in individual wells to lay eggs. Eggs were counted at time points 
24, 48, and 72 hr after being dosed. 
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Table 3-1 The Linear, Quadratic, and logarithmic Regressions for each dose of the total egg 
laying data set 
 
Dose Regression 
method 
Equation R2 Sig. 
Total egg laying data 
(0ppm) 
Linear 3.88 * x + -14.97 .982 <.001 
 Logarithmic -474.77 + 170.91 * 
log(x) 
.981 <.001 
Total egg laying data 
(1ppm) 
Linear 3.82 * x + -8.05 .936 <.001 
 Logarithmic -485.35 + 167.61 * 
log(x) 
.929 <.001 
Total egg laying data 
(3.16ppm) 
Linear 3.98 * x + -17.22 .961 <.001 
 Logarithmic -491.11 + 175.83 * 
log(x) 
.968 <.001 
Total egg laying data 
(10ppm) 
Linear 4.17 * x + -19.03 .972 <.001 
 Logarithmic -516.24 + 184.37* 
log(x) 
.982 <.001 
Total egg laying data 
(31.6ppm) 
Linear 4.15 -19.17 .980 <.001 
 Logarithmic -512.19 + 183.14 * 
log(x) 
.982 <.001 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 4: protein-coding gene expression analysis 
 
Abstract:  
 
Having a completely sequenced genome, such as that of Caenorhabditis elegans (C. 
elegans) which totals over 100 million base pairs, is an valuable tool we can use to more clearly 
understand the functions of its gene products (Hillier, Coulson et al. 2005; Schwarz 2005). This 
sequence lends itself to the formation of approximately 22,227 protein-coding genes, many of 
which have mutant alleles, providing us with a picture of at least the majority of the “players” 
involved (Spieth 2006). Many of these genes that have been sequenced have ancient origins, and 
are conserved in the domain eukarya, meaning they must be critical to properly function in the 
worm and animals in general. This is truly an incredible platform from which we can build and 
begin to truly understand the functions and mechanisms and the implications it means for 
metazoans (Hillier, Coulson et al. 2005; Schwarz 2005). Specifically in this study we aim to 
understated more clearly the functions and mechanisms of various genes after exposure to doses 
of nicotine by studying changes in gene expression.  
Introduction: 
 When Sydney Brenner selected C. elegans in 1965 for his studies of organism 
development and the nervous system it was because of its simple anatomy, and the ease of 
genetic manipulation (Brenner 1974; Hillier, Coulson et al. 2005). The problem he sought to 
solve was how genes might dictate complex structures and regulatory networks found in higher 
organisms (Brenner 1974). The search for a multicellular organism that could be maintained and 
analyzed with ease resulted in a clear identification of  C. elegans as a solution based on its 
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characteristics (Kenyon 1988). This approach has often proved successful for example, using the 
available C. elegans genome protein sequences (proteome) as a scaffold for identifying novel 
human genes, many biomedical researchers have been able characterize the function of many 
genes  in the human proteome (Lai, Chou et al. 2000; Kaletta and Hengartner 2006). 
C. elegans is an excellent model organism for research on this specific type of question. 
Genomic studies that compare genes, such as that of humans and C. elegans, offer a vast variety 
of candidates for the identification and functional mechanisms of human orthologous genes. In 
the C. elegans genome at least 83% (15,344 sequences) of the total 18,452 available C. elegans 
proteomes have human homologs. That is combined with the fact that approximately 7,954 
records of C. elegans proteins have matching human gene transcripts (Lai, Chou et al. 2000; 
Hillier, Coulson et al. 2005). That means that C. elegans is a great models for determining 
pathways and functions of many different genes. 
Protein-coding genes are genes that encode polypeptide chains that fold  into proteins 
(Spieth 2006). This is the largest class of any of the gene types in C. elegans, and is considered 
to be the workhorse for the cell due to their numerous functions. Approximately 25.5% of the 
genome appears to be protein-coding in C. elegans (Hodgkin 2005). Protein-coding genes 
maintain a variety of functions within most organisms. Variation in the regulation of these 
protein-coding genes and their functions has been shown to affect many processes and 
characteristics in the host organism (Andrew K. Jones 2003; Feng, Li et al. 2006). 
In this study we aim to look at the expression patterns of several protein-coding genes in 
response to nicotine, looking at different gene families to get an idea of effects of at the genomic 
level. We will the use this information to search for possible targets that may be regulated by 
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miRNAs. Genes with the highest and lowest expression as compared to nicotine untreated 
animals will be considered viable gene targets for miRNAs. We then can analyze the potential 
targeting miRNA expression pattern. 
Materials and methods: 
Synchronization 
In order to extract enough total rna sample C. elegans were densely grown in 100x15 
mm Petri dishes on nematode growth medium (NGM) and fed OP50 strain Escherichia coli 
according to a standard protocol (Hitchcock 1998; Brenner 2000), with Laval stage 3 from an 
age-synchronized culture used in all the experiments. To produce age-synchronized cultures, at 
2–3 days, eggs from mature adults were isolated using a synchronization solution, followed by 
rinsing with M9 buffer (Hitchcock 1998). After rinsing worms were placed on an NGM plate 
with no food for an arresting period to ensure all worm were closely synchronized.  
The worms were then transferred to NGM agar plates with a food source, resulting in 
synchronized adult worm populations. L3 larval stage worms were washed out using M9, rinsed, 
and then centrifuged at 2000 rpm for 2 min at room temperature a 2uL sample was taken and 
placed on a slide and counted under an inverse microscope to estimate the number of worms. 
Preparation of Nicotine Treatment 
A stock of 1,000 ppm nicotine was made from ACROSS organics L-nicotine, 98% pure 
(CAS 54-11-5) product. This was made by combining 10uL of L-nicotine with 9,990uL of 
distilled water. Five doses were chosen to test: control (0ppm), 1ppm 3.16ppm, 10ppm, 31.6ppm. 
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Doses were prepared to a volume of 20mL to accommodate the large amount of worms and 
ensure that the worms were equally exposed. 
C. elegans Nicotine Treatment 
Briefly, each test consisted of four concentrations and a control, in which the L3 stage 
worms from one densely grown 100x 15 mm nematode growth medium (NGM) petri dish, were 
transferred to a 50mL Falcon polystyrene conical tube containing nicotine dose. Each was made 
in 20 mL quantities from the 1,000ppm stock. These tubes were taped and placed in a rotator at 
42 rpm in an incubator at 200C.  The worms were exposed to the nicotine doses for 24 hours. 
After the 24 hr dosing period worms were collected and rinsed with M9 multiple times to remove 
any extra nicotine solution. Once rinsed, the worm pellet was transferred to a 1.5 mL 
microcenterfuge tube and all excess fluids were removed. The tubes were flash frozen in liquid 
nitrogen and then stored in a -800C freezer until ready for RNA extraction. 
Total RNA Extraction 
Total RNA was isolated from the dosed worms using the RNA/DNA/Protein Isolation 
Reagent from Applied Biosystems (Ambion, Austin, TX, USA) according to the manufacturer’s 
protocol. Total RNA was then quantified and assessed for quality using a Nanodrop ND-1000 
(Nanodrop Technologies, Wilmington, DE, USA). After quality was assessed, RNA samples 
were stored at -80°C until further analysis.  
RT-PCR and qRT-PCR for gene expressions   
Applied Biosystems TaqMan microRNA Assays were employed to detect and quantify C. 
elegans protein-coding genes and microRNA using real-time PCR according to the 
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manufacturer’s instructions. There were two steps in the TaqMan miRNA Assays: a) reverse 
transcription of the mature mRNA to a longer single-stranded cDNA sequence using a miRNA-
specific stem-looped primer, and b) quantitative real-time PCR. In short, a single-stranded cDNA 
was generated from 1 µg of the total RNA from the control, 1ppm, 3.16ppm, 10ppm, 31.6ppm 
nicotine exposed C. elegans tissue samples. Reverse transcription was reacted in 15 µL solution, 
which contained 500 ng of total RNAs, 1 mM each of dNTPs, 1 µL MultiScribe Reverse 
Transcriptase (50 U/µL), 1.5 µL 10X TR Buffer, 0.188 µL RNase Inhibitor, and 3 µL 5X 
Taqman RT primer. The reverse transcription reaction was performed with a Eppendorf 
Mastercycler Personal PCR machine (Westbury, NY) with the following temperature program: 
initial 16°C for 30 minutes followed by 42°C for 30 minutes; then, the reaction was held for 5 
minutes at 85°C; finally held at 4°C until next analysis or stored at -20°C.  
For the second step of the assay we performed the quantitative real time PCR (qRT-PCR) 
with a Poly T primer and a gene specific primer. Each reaction was performed in 20 µL solution, 
which contained 2 µL RT PCR product (10-fold dilution from RT PCR reaction), 10 µL Taqman 
2X Universal PCR Master Mix (No SmpErase UNG), and 1 µL Taqman MicroRNA Assays 20X 
Real Time Primers. Nuclease free water was used to adjust the final volume to 20 µL. The 
temperature program for qRT-PCR reactions were 95°C for 10 minutes followed by 45 cycles of 
95°C for 15 seconds (to denature DNA) and 60°C for 60 seconds (for primer annealing and 
extending).  
All reactions had three replicates and each dose had three replicates. In qRT-PCR, 
Y45F10D was employed as an endogenous reference gene for normalizing qRT-PCR results. 
The results were analyzed using the ∆∆Ct method. 
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Results: 
We tested several protein-coding genes for changes in expression. These genes belong to 
various families with a wide range of functions. They include: acr-16, acr-8, cat-4, egl-10, egl-
19, egl-49, egl-47, egl-5, hlh-14, lev-1, lev-8, lin-39, ric-3, unc-103, unc-29, unc-43, unc-50, unc-
68, sod-1, pink-1, oxi-1, age-1, and old-1.   
Table 4-1 shows the percentage of up/down-regulation for each tested gene. The highest 
up regulated gene was hlh-14, with an up regulation of 13,814% (138-fold up-regulated). 
Conversely the lowest down regulated gene was old-1, with a down regulation of 92% (12.5-fold 
down-regulated). Figure 4-1 is the graphical representation of the fold change expressed by each 
of the tested genes at various concentrations. The 3.16 ppm bar for hlh-14 (138-fold up-
regulated) was cut off in order to allow the other bars to be visible. 
 
Discussion: 
The “acr” families of genes are mainly associated with the alpha and non-alpha subunits 
of the nicotinic acetylcholine receptor (nAChR). The two candidates from this family that were 
tested are acr-16 and acr-8. The protein-coding gene acr-16, which encodes a nicotinic AChR 
subunit in C. elegans, is a homolog to the vertebrate α7 sub-unit (Francis, Evans et al. 2005). It 
was also shown that this gene mediated the nicotine-evoked ACh responses of the worm 
(Francis, Evans et al. 2005). Alternatively, in a separate study of acr-8 showed that it had no 
effect on either the levamisole-sensitive/insensitive components of the muscle ACh after its 
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deletion. Therefore, it is possible to hypothesize that the acr-8 is a non-essential subunit of the 
nicotinic receptor class in the ventral body wall muscles of C. elegans (Touroutine, Fox et al. 
2005). This may also explain the inverse relationship of the gene expression for these two 
protein-coding genes we observed in our assays 
The protein coding genes acr-8 and acr-16 display an inverse relationship to each other; 
while one was being up-regulated the other was down-regulated. Since both acr-8 and acr-16 are 
levamisole receptors in the muscle, they may be expressed differently due to the fact that acr-16 
is more important for cholinergic synaptic currents (Touroutine, Fox et al. 2005). Also the only 
dose at which each gene was unexpressed among all four doses was at the concentration of 3.16 
ppm, which may indicate regulation by gene expression is more sensitive at a specific dose of 
nicotine exposure. Table 4-2 gives a detailed explanation of the function of each of the specific 
genes used for this study.   
The “unc” family of genes deals with many facets of gene expression including 
locomotion and again the nicotinic acetylcholine receptor (nAChR). The list of candidates used 
from this family include: unc-103, unc-29, unc-43, unc-50, and unc-68. Gene deletions give an 
idea of the functions of these genes. For example, with the unc-103 gene deleted, hermaphrodites 
prematurely laid embryos that would normally be retained in the uterus for full development; this 
may indicate that the gene unc-103 is involved with egg-laying timing and muscle contraction 
(Reiner, Weinshenker et al. 2006). In our study this gene was down regulated at three ppm dosed 
concentrations possibly indicating that the exposure to nicotine causes this gene to be suppressed 
and caused an increase in premature egg laying. The up regulation of the “unc” genes at 10ppm 
may indicate a compensating mechanism exists when exposed to specific dose, basically an 
effort on the cells part to maintain normal egg-laying abilities. At higher concentrations the 
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expression of this gene is significantly down regulated possibly indicating cells have shifted 
from attempting to maintain normal function to a death cascade.   
The unc-29 gene has been shown to encode components of a nicotinic receptor that can 
promote egg-laying, but is not necessary for the muscle contractions needed for egg-laying (Kim, 
Poole et al. 2001). Our study shows that this gene was generally down regulated for the three 
tested concentrations and only slightly up regulated again at 3.16 ppm. This may indicate that 
after exposure to nicotine, this gene is suppressed and normal egg-laying promotion is decreased. 
The gene unc-50 has a homolog in humans called UNCL that is highly concentrated in 
the brain and is well conserved across many species (Fitzgerald, Kennedy et al. 2000). The gene 
unc-50 does not encode a nAChR subunit but appears to be required for proper nAChR assembly 
(Table 5-2). In this study unc-50 was up-regulated at all low doses except the highest dose, 31.6 
ppm, where it was slightly down regulated. This may indicate that upon exposure to nicotine, 
more receptors need to be assembled for binding of the large influx of nicotine. 
As seen in Table 4-1 and Figure 4-1, all the tested “unc” family genes except unc-43 
were up-regulated considerably at the concentration of 3.16 ppm. This again suggests that most 
nAChR related genes are turned on at certain exposure conditions. This is likely due to the fact 
that the nicotinic acetylcholine receptors (nAChRs) are pentameric membrane proteins that 
mediate excitatory synaptic transmission at neuromuscular junctions (Mongan, Jones et al. 
2002). Nicotine is a known substrate of these proteins so it may stimulate the expression of the 
receptors (Lam, Girard et al. 2007). 
The “cat” families of genes are mainly associated with catalase, a key antioxidant enzyme 
in the defense against oxidative stress. This gene is mainly down-regulated and only up-regulated 
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1.1 fold at a concentration of 10ppm. This suggests that under current exposure conditions, there 
is no significant oxidative stress.  
The “egl” families of genes are mainly associated with the formation of transcription 
factors and seven transmembrane G-protein-coupled receptors. We used several candidates from 
this family including: egl-10, egl-19, egl-49, egl-47, and egl-5. The egl-10 and egl-49 exhibit 3 
fold and 5.6 fold up-regulation at 1ppm, respectively, which are the genes most up-regulated at 
this low concentration. This indicates that egl-10 and egl-49 maybe “first response” genes to 
nicotine exposure. 
Many behaviors that are regulated by genes can be measured by performing behavioral 
assays. One study suggests that the egg-laying behavior in C. elegans is regulated in a nicotine 
dose-dependent manner by the gene egl-10 (Koelle and Horvitz 1996). It was proposed that egl-
10 may regulate G-protein signaling in the neural processes, since the egg-laying behaviors were 
dramatically affected in a loss-of-function egl-10 mutation. In our study, the gene egl-10 was 
highly up-regulated in all doses except at the concentration of 31.6 ppm, which was slightly 
down-regulated. This may reinforce that idea that in order to maintain proper egg-laying ability, 
egl-10 must be up-regulated to overcome the nicotine toxicity.  
Studies have shown that egl-19 may play an important role in the regulation of 
depolarization-induced calcium influx in C. elegans neurons (Laine, Frokjaer-Jensen et al.; 
Frokjaer-Jensen, Kindt et al. 2006). Loss of function mutants of this gene have been shown to 
lose the response to gentle touch stimulations, but are still able to move (Frokjaer-Jensen, Kindt 
et al. 2006). In our study there was a trend of down regulation by this gene as the concentration 
increases. This may contribute to the loss of normal movement that we observed at higher 
concentrations of nicotine. 
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In humans there is an abundance of the neural G-protein Gαo, whereas in C. elegans 
neurotransmission by this Gαo protein (egl-47) inhibits egg-laying behavior and could also serve 
as a model for studying signaling of G-protein (Moresco and Koelle 2004). In many of the doses 
that C. elegans were exposed to, this gene was down regulated, indicating egg-laying behavior 
would remain relatively normal or even increase. At 3.16 ppm this gene was up regulated 
meaning egg-laying should decrease, this indicates the involvement of this gene in complex 
signaling pathways when the gene regulation is the most active in this dose.  
The “hlh” families of genes are mainly associated with normal egg-laying, movement, 
body morphology, and larval development; more specifically, hlh-14 is required for proper 
neuronal development, particularly for regulation of the asymmetric cell division. The candidate 
from this family was hlh-14. Among all tested genes, hlh-14 had the highest up-regulated 
expression of more than 139 fold as compared to control at the concentration of 3.16 ppm (Table 
4-1 and Figure 4-1). This may indicate that upon exposure to nicotine these protein-coding genes 
must be up-regulated to maintain the proper development and function of the neurons. 
The “lev” families of genes are also associated with alpha and non-alpha subunits of the 
nicotinic acetylcholine receptor (nAChR). The candidates lev-8(alpha), lev-1(non-alpha) were 
generally up-regulated.  lev-1 is required for the normal locomotion and egg-laying behaviors, 
whereas lev-8 is required for normal rates of pharyngeal pumping and for fully wild-type 
responses (egg laying and body wall muscle contraction). A higher expression pattern is an 
indication that in the presence of the toxicant nicotine, these genes are required more to maintain 
normal functions lev-8 belongs to a nematode specific class of subunits and has been shown to 
be expressed in neurons, muscle cells, and epithelial-derived socket cells. C. elegans currently 
has the largest known nAChR subunit family of 27 nAChR subunits that have been identified 
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compared to just 16 in humans (Towers, Edwards et al. 2005). In our studies, lev-8 was up 
regulated at all concentrations and may indicate its importance in maintaining normal 
functioning of neurons and muscle cells upon exposure to a neurotoxicant such as nicotine. 
The last few gene families deal with oxidative stress. The sod-1 associated with the 
copper/zinc superoxide dismutase was down-regulated in all concentrations. This could be 
explained by unknown transcriptional feedback control mechanisms (Yanase, Onodera et al. 
2009). Studies also suggest that sod-1 and cat-4 do not play a role in the adaptive response 
against oxidative stress, so these genes remained down regulated under the tested exposure 
conditions (Yanase, Yasuda et al. 2002). The oxi-1 was up regulated at all concentrations and 
shows remarkable up-regulated expression of more than 102 fold at the concentration of 
3.16ppm. This indicates that there was increased oxidative stress associated with nicotine 
exposure. The old-1 is associated with a transmembrane tyrosine protein kinase (formerly TKR-
1),The complete up regulation of this gene at all doses might indicate that there may be increased 
need in phosphorylation of proteins, in order to activate/inactivate them, at this concentration 
thereby requiring an increased activity of this kinase (Murakami and Johnson 2001). 
Conclusion: 
In this study, we dosed C. elegans with various concentrations of nicotine and analyse 
changes in the expression of 23 selected protein coding genes. We were able to quantitatively 
determine the expression pattern changes in the transcription level of these genes across the dose 
range.  We were able to identify some nicotine sensitive genes which are up-regulated at low 
nicotine concentrations. We also concluded that the expression of individual genes are dose 
specific, possibly indicating a complex gene regulation network exists in response to nicotine 
exposure.    
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Table 4-1. Percentage of up/down-regulation for each tested genes.  
 1ppm 3.16ppm 10 ppm 31.6ppm 
acr-16 -43% 255% -36% -47% 
acr-8 53% -69% 73% 107% 
cat-4 -10% -26% 9% -16% 
egl-10 200% 2170% 66% -14% 
egl-19 108% 10% -14% -7% 
egl-49 460% 26% 490% 192% 
egl-47 -66% 416% -31% -88% 
egl-5 -78% 257% -2% 10% 
hlh-14 -33% 13814% 63% 21% 
lev-1 11% 30% -59% 9% 
lev-8 56% 115% 25% 12% 
lin-39 -72% 230% -74% 5% 
ric-3 1% 829% -12% -38% 
unc-103 -76% 1107% -85% -68% 
unc-29 -48% 116% -36% -25% 
unc-43 36% -43% 132% -13% 
unc-50 64% 983% 38% -8% 
unc-68 -33% 1163% 30% 151% 
sod-1 -35% -71% -28% -30% 
pink-1 -1% 26% 19% 12% 
oxi-1 44% 1014% 186% 22% 
age-1 12% 475% 75% -14% 
old-1 -85% 105% -92% -60% 
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Figure 4-1. Protein coding gene expression vs fold change. Here we have the expression analysis 
of the 23 protein coding genes selected for this study. The fold change was calculated using the 
d-dct method of qrt-pcr analysis 
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Table 4-2. List of selected genes with functional descriptions (per C. elegans database) 
Gene Function 
acr-16 acr-16 encodes an alpha-7-like homomer-forming subunit of the nicotinic 
acetylcholine receptor (nAChR) superfamily orthologous to human nicotinic 
cholinergic receptor alpha 7 (CHRNA7; OMIM:118511; possibly associated 
with schizophrenia and juvenile myoclonic epilepsy); ACR-16 functions as a 
ligand-gated ion channel that is required for the major fast cholinergic 
excitatory current at C. elegans neuromuscular junctions; an ACR-16::GFP 
reporter fusion expressed in muscle cells localizes to the tips of muscle 
arms, specific regions of the muscle cell membrane that form synapses with 
neuronal processes; acr-16::gfp promoter fusions also reveal expression in 
a subset of neurons; when expressed in Xenopus ooctyes, ACR-16 is active 
as a homomeric receptor and responds robustly to acetylcholine. 
acr-8 acr-8 encodes an alpha subunit of nicotinic acetylcholine receptor (nAChR); 
ACR-8 falls into the 'ACR-8' class of nAChR subunits, which includes ACR-
12 and ACR-13. 
cat-4 cat-4 encodes an ortholog of the human GTP cyclohydrolase I gene (GCH1; 
OMIM:600225), which when mutated leads to dystonia; CAT-4 is involved 
in serotonin and dopamine biosynthesis that affects movement, mating 
behavior, foraging behavior, and cell migration; CAT-4 acts in the same 
genetic pathway as flp-1 
egl-10 egl-10 encodes an RGS protein, expressed in neurons, that affects egg laying 
and negatively regulates GOA-1 (Galpha[o]) signalling; it requires the 
Gbeta(5) ortholog GPB-2 for this activity, and genetically interacts with the 
egl-30 and goa-1 signaling pathways 
egl-19 egl-19 encodes an ortholog of the alpha subunit of mammalian L-type 
calcium ion channels that affects muscle contraction in late embryonic 
morphogenesis, movement, egg-laying, mating and feeding; egl-19 is 
expressed in muscle cells and some neurons 
egl-49 egl-49 was identified in screens for genes required for development and 
function of the hermaphrodite specific motor neurons (HSNs) required for 
egg laying; mutations in egl-49 result in HSNs that are functionally 
defective but morphologically normal. 
egl-47  egl-47 encodes two seven transmembrane G-protein-coupled receptors; 
while loss-of-function mutations in egl-47 result in no detectable egg-laying 
defects, gain-of-function mutations and overexpression studies suggest that 
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EGL-47 is required for negatively regulating activity of the hermaphrodite-
specific motor neurons (HSNs) that control egg laying; EGL-47::GFP 
reporters made with either of the two isoforms indicate that EGL-47 is 
expressed in a small subset of head neurons, the HSNs, and the PVQ tail 
interneurons; in addition, a reporter made with the longer isoform, EGL-
47A, is expressed in vulval cells in L4 larvae; in adults, the only cells of the 
egg-laying system that express EGL-47 are the HSNs; genetic and 
overexpression studies suggest that, in the HSNs, EGL-47 signals through 
the G-alpha protein GOA-1 to inhibit egg laying. 
hlh-14 hlh-14 encodes a basic helix-loop-helix (bHLH) transcription factor that is 
one of five C. elegans Achaete-Scute family homologs; HLH-14 activity is 
required generally for normal egg-laying, movement, body morphology, and 
larval development; more specifically, HLH-14 is required for proper 
neuronal development, particularly for regulation of the asymmetric cell 
division that gives rise to the PVQ/HSN/PHB neuroblasts and for normal 
differentiation of these neuroblast descendants, including their cell division 
patterns, migrations, and neurotransmitter expression; in specifying neuronal 
cell fates, genetic evidence suggests that hlh-14 acts together with hlh-2, 
which encodes the C. elegans E/Daughterless ortholog; HLH-14 is expresed 
exclusively in the embryo and detected in the left and right PVQ/HSN/PHB 
neuroblasts and their descendants, as well as in other cells identified, 
tentatively, as anterior neuroblasts and posterior neuroblasts such as Caapa. 
egl-47 egl-47 encodes two seven transmembrane G-protein-coupled receptors; 
while loss-of-function mutations in egl-47 result in no detectable egg-laying 
defects, gain-of-function mutations and overexpression studies suggest that 
EGL-47 is required for negatively regulating activity of the hermaphrodite-
specific motor neurons (HSNs) that control egg laying; EGL-47::GFP 
reporters made with either of the two isoforms indicate that EGL-47 is 
expressed in a small subset of head neurons, the HSNs, and the PVQ tail 
interneurons; in addition, a reporter made with the longer isoform, EGL-
47A, is expressed in vulval cells in L4 larvae; in adults, the only cells of the 
egg-laying system that express EGL-47 are the HSNs; genetic and 
overexpression studies suggest that, in the HSNs, EGL-47 signals through 
the G-alpha protein GOA-1 to inhibit egg laying. 
lev-1 lev-1 encodes a non-alpha subunit of nicotinic acetylcholine receptor 
(nAChR) which, when mutated, confers resistance to levamisole; LEV-1 is 
required for completely normal locomotion, regulation of egg-laying 
behavior, and forms a cation channel when coexpressed with UNC-38 or 
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UNC-63 and UNC-29; LEV-1 falls into the 'UNC-29' class of nAChR 
subunits, which includes UNC-29, ACR-2, and ACR-3; a LEV-1::GFP 
fusion protein is expressed in all body wall muscle cells and a subset of 
ventral cord motor neurons. 
lev-8 lev-8 encodes a novel nicotinic acetylcholine receptor (nAChR) alpha 
subunit that is a member of the ACR-8 group of nAChR subunits; LEV-8 
activity is required for normal rates of pharyngeal pumping and for fully 
wild-type responses (increased egg laying and body wall muscle 
contraction) to the nAChR agonist and antihelmintic levamisole; expression 
of a LEV-8::GFP reporter construct begins at the L1 larval stage and is 
detected in neurons, body wall and uterine muscle cells, and socket cells of 
the IL and OL mechanosensory neurons; expression in body wall muscles is 
strongest in the anterior, consistent with increased levamisole resistance of 
head, or anterior, muscles seen in lev-8 mutant animals 
lin-39 encodes a homeodomain protein homologous to the Deformed and Sex 
combs reduced family of homeodomain proteins; lin-39 is required cell 
autonomously for specification of mid-body region cell fates, including 
those of the VC neurons and the vulval precursor cells (VPCs), during 
postembryonic development; lin-39 activity is also required for normal 
migration of the QR, and to a lesser extent QL, neuroblasts and their 
descendants; in regions of the body where lin-39 expression overlaps with 
that of mab-5, another C. elegans HOM-C gene, the two genes appear to 
either compensate for one another's activity or act combinatorially to 
promote cell fates distinct from those where either gene is expressed alone; 
lin-39 transcripts are detected at all development stages, and a lin-39:lacZ 
reporter fusion is expressed in cells of the central body region, including 
ventral cord neurons and ventral epidermal cells, from mid-embryogenesis 
through larval and adult stages. 
ric-3  encodes a novel, highly charged protein with two transmembrane domains 
and extensive coiled-coil domains; RIC-3 is necessary for the maturation 
and function of at least four nicotinic acetylcholine receptors; specifically, it 
is needed for assembly or trafficking of the DEG-3 nicotinic acetylcholine 
receptor; RIC-3 levels and hence, activity, are regulated by BATH-42, a 
BTB and MATH domain-containing protein, with which RIC-3 interacts in 
vitro; as BATH-42 also interacts with the CUL-3 cullin, RIC-3 levels are 
thus likely regulated by a CUL-3-containing ubiquitin ligase complex 
unc-29 unc-29 encodes an non-alpha subunit of the nicotinic acetylcholine receptor 
(nAChR) superfamily; UNC-29 is required for normal locomotion and egg-
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laying, and functions as a subunit of a ligand-gated ion channel that likely 
mediates fast actions of acetylcholine at neuromuscular junctions and in the 
nervous system; when coexpressed with LEV-1, a non-alpha nAChR 
subunit, and UNC-38 or UNC-63, alpha AChR subunits, the resulting 
multimer can form levamisole-gated channels; UNC-29 is expressed in body 
wall muscle 
unc-38 unc-38 encodes a nicotinic acetylcholine receptor (nAChR) alpha subunit; 
UNC-38 is required for normal locomotion and egg-laying, and functions as 
a subunit of a ligand-gated ion channel that likely mediates fast actions of 
acetylcholine at neuromuscular junctions and in the nervous system; when 
coexpressed with ACR-2, ACR-3, UNC-29, and LEV-1, non-alpha nAChR 
subunits, the resulting multimer can form levamisole-gated channels; UNC-
38 is expressed postsynaptically in muscles and neurons where it colocalizes 
with TAX-6, and with ACR-8, ACR-12, and UNC-29, respectively 
unc-50 unc-50 encodes an integral membrane protein orthologous to the 
Saccharomyces cerevisiae Golgi component Gmh1p; UNC-50 is required for 
regulating subtype-specific nicotinic receptor trafficking to the cell surface 
and thus, for normal synaptic transmission at the neuromuscular junction; 
UNC-50 is ubiquitously expressed from early embryogenesis to adulthood 
and localizes to the Golgi 
unc-43 unc-43 encodes the C. elegans ortholog of type II calcium/calmodulin-
dependent protein kinase (CaMKII); unc-43 activity is required for a number 
of processes, including locomotion, neuronal cell fate specification and 
regulation of synaptic density, egg laying, defecation, and meiotic 
maturation; in regulating some of these processes, unc-43 acts in concert 
with MAPKKK and G protein signaling pathways; UNC-43 is expressed in 
neurons, oocytes, and gonadal sheath cells; UNC-43 can regulate the activity 
of the EGL-2 ether-a-go-go potassium channel with which it physically 
interacts. 
unc-68 unc-68 encodes a ryanodine receptor ortholog that is expressed in body-wall 
muscle cells and is required for normal body tension and locomotion; unc-68 
mutants are flaccid, sluggish, and resistant to ryanodine, but have normal 
muscle ultrastructure; UNC-68 is dispensable for excitation-contraction 
coupling itself, but may amplify its calcium signals; the unc-68/kra-1(kh30) 
mutation is an S1444N substitution at a putative protein kinase C 
phosphorylation site; UNC-68 reduced unc-103(sy557)-induced spicule 
protraction by one half; unc-68 is orthologous to the human genes RYR1 
(OMIM:180901, mutated in malignant hyperthermia and central core 
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disease), RYR2 (OMIM:180902, mutated in stress-induced polymorphic 
ventricular tachycardia), and RYR3 (OMIM:180903) 
unc-
103 
unc-103 encodes an ERG-like K+ channel homolog, orthologous to human 
KCNH6 (OMIM:608168); UNC-103 regulates muscle activation in motility, 
egg-laying and male spicule protraction; UNC-103 is expressed highly in 
many neurons; gain-of-function alleles can be uncoordinated, while loss-of-
function alleles have a more subtle defect in copulatory spicule protraction 
sod-1 sod-1 encodes the copper/zinc superoxide dismustase, an enzyme that is 
known to protect cells from oxidative damage; superoxide dismutase activity 
can be detected in worm extracts; sod-1 activity has been implicated in the 
increased life-span of dauer larvae where this enzyme demonstrates the 
highest activity compared to other life-stages as well as in the increased life 
span of age-1 mutants and their resistance to oxidative damage; sod-1 
modulates the effect of let-60 ras on vulval and germline development via 
cytoplasmic reactive oxygen species; unlike other eukaryotic superoxide 
dismutases, sod-1 does not require the copper chaperone CCS for its activity 
and instead uses a glutathione pathway for acquiring copper; in humans, 
mutation of SOD1 (OMIM:147450) leads to amyotrophic lateral sclerosis 
(OMIM:105400) 
pink-1 pink-1 encodes a predicted serine/threonine protein kinase that is most 
similar to the Drosophila and human PINK1 (PTEN-induced kinase) protein 
kinases, the latter of which has been implicated in familial forms of 
Parkinson's disease; although loss of C. elegans pink-1 activity via large-
scale RNAi screens results in no obvious abnormalities, studies in 
Drosophila indicate that Drosophila PINK1 is a mitochondrial protein that 
genetically interacts with Drosophila parkin and is essential for maintaining 
mitochondrial function and integrity in several tissues, including flight 
muscles and dopaminergic neurons 
age-1 age-1 encodes the C. elegans ortholog of the phosphoinositide 3-kinase 
(PI3K) p110 catalytic subunit; AGE-1, supplied maternally and 
embryonically, is a central component of the C. elegans insulin-like 
signaling pathway, lying downstream of the DAF-2/insulin receptor and 
upstream of both the PDK-1 and AKT-1/AKT-2 kinases and the DAF-16 
forkhead type transcription factor, whose negative regulation is the key 
output of the insulin signaling pathway; in accordance with its role in insulin 
signaling, AGE-1 activity is required for regulation of metabolism, life span, 
dauer formation, stress resistance, salt chemotaxis learning, fertility, and 
embryonic development; although the age-1 expression pattern has not yet 
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been reported, ectopic expression studies indicate that pan-neuronal age-1 
expression is sufficient to rescue life-span defects, while neuronal, intestinal, 
or muscle expression can partially rescue dauer formation, and neuronal or 
muscle expression can rescue metabolic defects 
old-1 old-1 encodes a receptor protein tyrosine kinase; old-1 activity is required 
for stress resistance and regulation of adult lifespan: old-1 mRNA 
expression is upregulated in response to stress and in daf-2 and age-1 mutant 
backgrounds; likewise, overexpression of old-1 in wild-type animals extends 
lifespan and increases resistance to heat and UV irradiation; an OLD-1::GFP 
fusion protein is expressed in the anterior region of worms, in neuronal, 
hypodermal, and pharyngeal tissues, as well as in the proximal region of the 
male gonad; expression is visible in young adults and appears to increase as 
animals age and in response to heat, starvation, or UV irradiation. 
oxi-1 oxidative stress Induced 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 5: miRNA gene expression analysis 
 
Abstract:  
 
The effects of nicotine on protein coding genes and their targeting miRNAs have rarely 
been studied. In this study we aim to further explore the effects of  nicotine exposure on the 
expression of several selected miRNA genes, this focus on miRNA gene expression will be 
performed through the use of qRT-PCR.  The miRNAs that were selected were predicted in-silico 
through the use of two computational target prediction miRNA data bases, miRNA.org and 
miRNAmap, to target the protein-coding genes analyzed in the previous chapter, the four 
different miRNAs were: Cel-mir-70, Cel-mir-58, Cel-mir-790, and Cel-mir-253. Of the miRNAs 
tested, Cel-mir-70 was the only one that showed an inverse relationship, as expected, with a 
miRNA and its protein-coding gene target. All other miRNAs did not show this inverse 
relationship, indicating that either they may not be the real regulators of the genes we analyzed 
or the miRNAs are not playing a role. This reinforces the idea that miRNA regulation of protein-
coding genes is a very fluid and dynamic process. Understanding these expression patterns of the 
miRNAs will lead to a better understanding of their functions in gene regulation.  
Introduction: 
 In a multicellular organism, one way to understand gene function is to understand how the gene 
works: when, where, and under what conditions a gene is expressed (Hillier, Coulson et al. 2005) . The 
toxicological results that are obtained from research pertaining to C. elegans are very likely 
relevant to higher animals including humans (Bischof, Huffman et al. 2006). The ability to 
perform genetic screens of the entire genome of C. elegans allows for a deeper insight into the 
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action of toxins, such as nicotine. Seeing the effects of various toxins and how  C. elegans 
genome responds could lead to a greater understanding of molecular and genetic mechanisms 
(Bischof, Huffman et al. 2006).   
C. elegans is an excellent model organism for exploring the genetic basis of toxicant 
actions important to human life. Also, they are particularly useful for the study of the 
ecotoxicological relevance of chemically induced responses of genes (Roh, Lee et al. 2006; Roh, 
Park et al. 2009). The complete genome of C. elegans is known and is very information-rich.  
Approximately 25.5% of the genome appears to be protein-coding, while genes that include: 
introns, 5’ and 3’ untranslated regions and regulatory regions take up altogether at least 40 % of 
the whole genome (Hodgkin 2005; Jones, Davis et al. 2007). microRNAs (miRNAs) are a class 
of small (~21 nt) endogenous gene regulators.  miRNAs are genomically-encoded, untranslated 
RNA molecules of approximately 20-25 nucleotides (nt) in length (Ambros; Ambros 2004; 
Bartel 2004; Baskerville and Bartel 2005). They negatively control gene expression at the post 
transcriptional level by binding to targeting messenger RNA (mRNAs) and inhibit translation of 
mRNAs via imprecise antisense base-pairing and act by one of two mechanisms: labeling and 
targeting mRNA for degradation, or by inhibiting mRNA translation (Ambros, Lee et al. 2003; 
Bartel 2004; Ambros and Chen 2007). They control diverse processes such as cell fate 
specification, apoptosis, developmental timing, diseases, and metabolism (Sulston and Brenner 
1974). The C. elegans genome encodes many miRNAs (Bartel 2004; Ambros and Chen 2007; 
Miska, Alvarez-Saavedra et al. 2007). Many of the C. elegans miRNAs are highly evolutionarily 
conserved from flies to humans (Vella 2005). The first miRNA identified in C. elegans was lin-4, 
reported by Victor Ambros and colleagues in 1993 (Vella 2005). The C. elegans genome encodes 
hundreds of miRNAs. Current literature indicates that 175 miRNAs have been identified in C. 
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elegans so far (MIR-Base). Many of the C. elegans miRNAs are highly evolutionarily conserved 
from flies to humans (Lai, Chou et al. 2000; Narahashi, Fenster et al. 2000; Nass and Hamza 
2007). 
miRNA genes are normally found in the intergenic and intronic regions of the genome 
(Baskerville and Bartel 2005). The transcription of the miRNA genes is performed by RNA 
polymerase II resulting in primary miRNAs transcripts (pri-miRNA) (Roush and Slack 2009).  
Similarly to the protein-coding targets of RNA Pol II, pri-miRNAs are processed into pre-
miRNAs in the nucleus by the microprocessor complex (Denli, Tops et al. 2004) . The 
premiRNAs are then exported to the cytoplasm by Exportin 5, where they are further processed 
by Dicer into mature miRNAs (Yi, Qin et al. 2003; Dempsey, Mackenzie et al. 2005).  
Biogenesis of the C. elegans miRNA is a well-known process and occurs in a similar 
manner in vertebrates.  After the transcription of a miRNA gene, nuclear cleavage of the pri-
miRNA by the Drosha RNase III endonucleases occurs. This enzyme cuts both strands of the pri-
miRNA near the stem loop and generates~60–70 nt stem-loop shaped miRNA precursor (pre-
miRNA) (Sulston and Brenner 1974). This pre-miRNA is transported to the cytoplasm by the 
export receptor Exportin-5. The nuclear cut by Drosha defines one end of the mature miRNA and 
cytoplasmic cut by Dicer, also RNase III endonuclease, defines the opposite one. Dicer 
recognizes the pre-miRNA and cuts both of its strands at about two helical turns away from the 
base of the stem loop. Then the mature miRNA is associated with RNA-induced silencing 
complex (RISC) (Vella 2005). Once incorporated into a cytoplasmic RISC, the miRNA will 
specify cleavage if the miRNA has sufficient complementarity to the mRNA, or it will repress 
productive translation if the miRNA does not have sufficient complementarity. These miRNAs 
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down-regulate gene expression by interacting with partially complementary sequences in the 3' 
UTRs of their target genes (Sulston and Brenner 1974).  
The mature single-stranded miRNA binds to messenger RNAs (mRNAs) to interfere with 
their translational processing. It is estimated that a very small amount of our DNA actually 
encode for these miRNA (~1%), but those miRNA regulate nearly one-third of our encoded 
reference genes. Over recent years there has been a flourish of different and exciting methods 
developed to ascertain the exact function and mechanics for these miRNAs. Various 
bioinformatics databases, tools, and algorithms have been developed to help predict the 
sequences of miRNAs and their target genes. These various tools used in combination with in 
silico approaches; provide new bioengineering approaches for fine-tuning gene regulation. 
 Investigations on miRNAs offer new and exciting opportunities for scientists with 
bioengineering. Manipulation and understanding of these miRNA activities can lead to the 
integrative understanding of the gene network regulation from the molecular to the systems 
levels. Clinical applications also abound such as drug design for, possible treatments of diseases 
and addiction in addition to diagnostic innovations (Sun, Julie Li et al. 2010). Computational and 
bioinformatics studies can help develop new ways to design miRNAs for the enhancement of 
these applications towards understanding addiction and miRNA’s involvement. Improved 
innovative algorithms and analysis methods are essential for the further advancement of this type 
of research field. 
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Materials and methods: 
Synchronization 
C. elegans were densely grown in 100x15 mm Petri dishes on nematode growth medium 
(NGM) and fed OP50 strain Escherichia coli according to a standard protocol (Hitchcock 1998; 
Brenner 2000), with Laval stage 3 from an age-synchronized culture used in all the experiments. 
To produce age-synchronized cultures, at 2–3 days, eggs from mature adults were isolated using 
a synchronization solution, followed by rinsing with M9 buffer (Hitchcock 1998). After rinsing 
worms were placed on an NGM plate with no food for an arresting period to ensure all worm 
were closely synchronized. 
The worms were then transferred to agar plates with a food source, resulting in 
synchronized adult worm populations. L3 larval stage worms were washed out using M9, rinsed, 
and then centrifuged at 2000 rpm for 2 min at room temperature a 2uL sample was taken and 
placed on a slide and counted under an inverse microscope to estimate the number of worms. 
Preparation of Nicotine Treatment 
A stock of 1,000 ppm nicotine was made from ACROSS organics L-nicotine, 98% pure 
(CAS 54-11-5) product. This was made by combining 10uL of L-nicotine with 9,990uL of 
distilled water. Five doses were chosen to test: control (0ppm), 1ppm 3.16ppm, 10ppm, 31.6ppm. 
Doses were prepared to a volume of 20mL to accommodate the large amount of worms and 
ensure that the worms were equally exposed. 
C. elegans Nicotine Treatment 
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Briefly, each test consisted of four concentrations and a control, in which the L3 stage 
worms from one densely grown 100x 15 mm nematode growth medium (NGM) petri dish, were 
transferred to a 50mL Falcon polystyrene conical tube containing nicotine dose. Each was made 
in 20 mL quantities from the 1,000ppm stock. These tubes were taped and placed in a rotator at 
42 rpm in an incubator at 200C.  The worms were exposed to the nicotine doses for 24 hours. 
After the 24 hr dosing period worms were collected and rinsed with M9 multiple times to remove 
any extra nicotine solution. Once rinsed, worm pellet was transferred to a 1.5 mL 
Microcenterfuge tube and all excess fluids were removed. The tubes were then flash frozen in 
liquid nitrogen and then stored in a -800C freezer until ready for RNA extraction. 
Total RNA Extraction 
Total RNA was isolated from the whole C. elegans homogenate using the 
RNA/DNA/Protein Isolation Reagent from Applied Biosystems (Ambion, Austin, TX, USA) 
according to the manufacturer’s protocol. Total RNA was then quantified and assessed for 
quality using a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE, USA). After 
quality was assessed and deemed of high enough quality, having a ratio of nucleic acids to 
protein (260/280) of between 2.0 and 2.2 and a ratio of nucleic acids to organic compounds in 
solution (phenol, trizol and others aromatics like these) (260/230) of 1.5 to 2.0 organic 
compounds in solution (phenol, trizol and others aromatics like these)., RNA samples were 
stored at -80°C until further analysis.  
 
RT-PCR and qRT-PCR for MicroRNA gene expressions   
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In total, we investigated changes in the expression levels of four different miRNAs cel-
miR-70, cel-miR-58, cel-miR-790, and cel-miR-253.  The miRNAs that were selected were 
predicted in-silico through the use of two computational target prediction miRNA data bases, 
miRNA.org and miRNAmap, to be the targets of the protein-coding genes selected in the 
previous chapter. One housekeeping gene (Y45F10D) was used as reference gene to normalized 
expression values. Applied Biosystems TaqMan microRNA Assays were employed to detect and 
quantify C. elegans protein-coding genes and miRNA using real-time PCR according to the 
manufacturer’s instructions. There were two steps in the TaqMan miRNA Assays: a) reverse 
transcription of the mature miRNA to a longer single-stranded cDNA sequence using a miRNA-
specific stem-looped primer, and b) quantitative real-time PCR. In short, a single-stranded cDNA 
was generated from 1 µg of the total RNA from the control, 1ppm, 3.16ppm, 10ppm, 31.6ppm C. 
elegans tissue samples by reverse transcription using the Applied Biosystems RNA/DNA/Protein 
Isolation Reagent. Reverse transcription was reacted in 15 µL solution, which contained 500 ng 
of total RNAs, 1 mM each of dNTPs, 1 µL MultiScribe Reverse Transcriptase (50 U/µL), 1.5 µL 
10X TR Buffer, 0.188 µL RNase Inhibitor, and 3 µL 5X Taqman RT primer. The reverse 
transcription reaction was performed with a Eppendorf Mastercycler Personal PCR machine 
(Westbury, NY) with the following temperature program: initial 16°C for 30 minutes followed 
by 42°C for 30 minutes; then, the reaction was held for 5 minutes at 85°C; finally held at 4°C 
until next analysis or stored at -20°C.  
For the second step of the assay we performed the quantitative real time PCR (qRT-PCR) 
with a Poly T primer. Each reaction was performed in 20 µL solution, which contained 2 µL RT 
PCR product (10-fold dilution from RT PCR reaction), 10 µL Taqman 2X Universal PCR Master 
Mix (No SmpErase UNG), and 1 µL Taqman MicroRNA Assays 20X Real Time Primers. 
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Nuclease free water was used to adjust the final volume to 20 µL. The temperature program for 
qRT-PCR reactions were 95°C for 10 minutes followed by 45 cycles of 95°C for 15 seconds (to 
denature DNA) and 60°C for 60 seconds (for primer annealing and extending).  
All reactions had three replicates and each dose had three replicates. In qRT-PCR, 
Y45F10D was employed as an endogenous reference gene for normalizing qRT-PCR results. 
The results were analyzed using the ∆∆Ct method. 
Selection of miRNAs 
Currently, there are a large number of tools or algorithms that have been developed for 
computational target prediction. Although the principles of these tools or algorithms are mainly 
focused on complementarity between the seed region of the miRNA and the predicted target, 
there are quite differences on predicted targets using different tools or algorithms. Also, since 
few validated miRNA targets are known, it is hard to tell which tool or algorithm has the best 
performance.  
In order to select for the mRNA (protein-coding genes selected) targets for our miRNAs, 
we used two online miRNA data bases including: miRNA.org and miRNAmap. These are online 
data bases of the predicted mRNA targets of many of the miRNAs found in several species 
including: Homo sapiens, Drosophila melanogaster, and Caenorhabditis elegans. We used two 
data bases to increase our confidence that the selected miRNA were in fact targets of the selected 
protein-coding genes. Once a list was compiled of the predicted miRNa targets for each database 
the final selections were based upon both databases revealing the same miRNA targets. 
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Results: 
As shown in Figure 5-1,  cel-miR-70 showed different expression levels at different 
concentrations: at concentration 1ppm it was shown to be down-regulated 14.3 fold, at 
concentration 3.16 ppm it was shown to be up-regulated 1.34 fold, at concentration 10 ppm again 
a down-regulation of 33.3 fold, finally at concentration 31.6 there was a down regulation of 100 
fold, at which the expression was close to the threshold level. This miRNA was also predicted to 
be the target of another selected protein-coding gene, egl-10. The expression levels were very 
similar so they were combined in figure 5-2.  
Cel-miR-58 also showed various expression levels at different concentrations: at 
concentration of 1ppm it was down-regulated of 14.3 fold, at concentration of 3.16 ppm it was 
up-regulated 4.57 fold, at concentration of 10 ppm again a down-regulation of 8.3 fold, finally at 
concentration of 31.6 ppm there was a down regulation 10 fold. 
 Similarly, the cel-miR-790 was only up regulated at concentration of 3.16 ppm 1.87 fold. 
At concentrations of 1ppm, 10ppm, and 31.6 ppm it was down regulated 9.1, 16.7, and 16.7 fold 
respectively. 
Again the cel-miR-253 showed similar expression patterns as others; only at the 
concentration of 3.16ppm it was up-regulated 1.8 fold . At concentrations of 1ppm, 10ppm, and 
31.6 ppm it was down regulated 10, 16.7, and 200 fold, respectively, where the expression was 
very low. 
Fold- change results were then graphed alongside their protein coding gene targets in 
(Figure 5-2).  
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Discussion: 
Recent studies have shown that the expression of miRNAs, an important class of gene 
regulators, can be altered when an organism is exposed to a toxicant.  Studies similar to this one 
have been performed in various model organisms. In this study we investigated changes in 
expression levels of four miRNAs, selected because they were predicted targets of the protein 
coding genes that were shown to be highly up/down regulated after exposure to various 
concentrations of nicotine in C. elegans.  
Using RT-PCR and qRT-PCR, we analyzed the expression patterns in four different 
miRNAs in L-3 synchronized C. elegans after exposure to various concentrations of nicotine. 
We found that all the four miRNAs were down regulated excepted at one tested concentration of 
3.16ppm (19.5µM). This study may suggest that microRNAs may be induced and more active at 
specific low concentrations.   
Cel-miR-70, a miRNA involved in regulating genes encoding the alpha subunit of 
nicotinic acetylcholine receptor (nAChR), was down-regulated after exposure to 1ppm, 10ppm, 
and 31.6ppm of nicotine. At 3.16 ppm (19.5µM) it was up-regulated. This expression pattern was 
reversely related to its potential targeting gene acr-8, which was down-regulated only at 3.16ppm   
and up regulated  at 1ppm, 10ppm, and 31.6ppm of nicotine.  The expression of miRNA and its 
potential gene targets should be inversely related. The Cel-miR-70 is likely a real target of acr-
8/egl-10. This is an example of a miRNA that can directly regulate the expression of its target 
genes (Figure 5-2) (Bracht, Van Wynsberghe et al.). 
Cel-miR-58, a miRNA that is involved with the controlling of the encoding of two seven 
transmembrane G-protein-coupled receptors, was the most up-regulated at the concentration of 
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3.16ppm (4.5fold) among all four tested miRNAs. Although it was predicted by the data bases 
that cel-mir-58 could potentially target egl-47, the data in this case suggests otherwise, due to the 
fact that the expression pattern of the protein-coding gene and the miRNA are not inversely 
related as seen (Figure 5-2). Another possibility is that there is another unchecked miRNA 
paralog that may also act on these protein-coding genes resulting in a combined up/down 
regulation. In humans, the gene that is homologous to this cel-mir-58 is hsa-miR-450b-3p 
(Ibanez-Ventoso, Vora et al. 2008). 
Cel-miR-790, a miRNA that encodes an ERG-like K+ channel homolog, orthologous to 
human KCNH6, was down regulated at 1ppm, 10ppm, and 31.6ppm concentrations of nicotine.. 
It was shown to be the second most up-regulated at the concentration of 3.16 ppm, when 
compared to the other four miRNAs. Although the data base predictions showed that Cel-miR-
790 potentially target unc-103, the expression pattern of unc-103 at each concentration seems not 
to be inversely related to the expression of Cel-miR-70, as seen in (Figure 5-2), as it would be if 
it were a real target. Again this has a possible explanation of several unchecked miRNAs having 
the same target. This particular miRNA has been shown to have at least seven other miRNAs 
homologs in C. elegans and four in humans (Ibanez-Ventoso, Vora et al. 2008). It is thought that 
some miRNA may act redundantly within family types that are homologs (Kaufman and Miska). 
Cel-miR-253, a miRNA that regulates the copper/zinc superoxide dismutase, which is 
known to be induced under high oxidative stress (Chen, Shan et al. 2003; Guan, Yu et al. 2003; 
Yu, Nordberg et al. 2003), was found down-regulated in C. elegans after exposure to increasing 
concentrations of nicotine. As seen in the previous example with the other miRNAs, the change 
in expression point occurred at the 3.16 ppm dose. It is possible that cel-miR-253 is only induced 
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under high concentrations and at extremely high concentrations becomes inactive by some 
means.  
There are some emerging studies that suggest that many miRNAs act redundantly with 
other miRNAs or other pathways, meaning it is possible for more than one miRNA to function to 
up/down-regulate a particular protein-coding gene (Miska, Alvarez-Saavedra et al. 2007).  While 
fewer than 25% of protein-coding genes have a recognizable paralog in the C. elegans genome, 
about 60% of miRNAs are members of a family of two to eight genes 
Conclusion: 
The genetic analysis of miRNA genes in model organisms such as C. elegans is 
beginning to put into place the pieces of a mosaic that will eventually show us the range of 
functions that miRNAs have in the control of animal development and physiology (Ambros 
2004). To assess the possible involvement and function of these miRNAs, studies like this one 
will continue to paint a picture of gene regulation and expression of miRNAs across all the phyla. 
This picture will eventually be able to answer questions like: Can miRNAs be activated and 
repress their targeting gene expression?  
In this study we analyzed the expression of four miRNAs (cel-miR-70, cel-miR-58, cel-
miR-790, cel-miR-253) selected after blasting to find potential miRNA targets of the selected 
protein-coding genes. The miRNAs were tested after exposure to various concentrations of 
nicotine including: control (0ppm), 1ppm, 3.16ppm, 10ppm, 31.6ppm (which corresponds to 
6.17µM, 19.5µM, 61.7µM, and 194.5µM respectively). We found that individual miRNA 
expression profiles varied between the different concentrations, indicating that the nicotine 
concentration induces a differential miRNA expression.  
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When compared to the results of the protein-coding gene analysis, only one miRNA (Cel-
miR-70) showed the inverse relationship expected if it were a true targeting miRNA. The rest of 
the miRNAs did not show this relationship, it can be concluded that maybe these are not true 
targeting miRNAs for the selected protein-coding genes 
Therefore, we believe that miRNAs may play a key role in controlling protein-coding 
gene expression. Furthermore we believe that the understanding of this relationship between the 
toxicant (nicotine) and its effects on miRNAs will lead to a greater understanding and treatment 
of nicotine addiction. C. elegans is an appropriate model for studying nicotine’s effects on not 
only miRNAs but protein-coding genes and the cytotoxicity as well. As mentioned before both 
humans and C. elegans share many pathways and mechanisms, any model that can help elucidate 
the various effects of different toxicants is a valuable tool for research.  
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Figure 5-1. Gene expression analysis of four miRNAs after exposure to various concentrations 
(ppm) of nicotine.  Results of the qrt-PCR were analyzed using the ∆∆Ct method and fold 
changed was graphed  
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Figure 5-2. Gene expression analysis of the protein-coding gene target and the predicted 
targeting miRNAs after exposure to various concentrations (ppm) of nicotine.  Results of the qrt-
PCR were analyzed using the ∆∆Ct method and fold changed was graphed 
 
 
